Todays approval represents an important milestone for paediatric patients living with type-2 diabetes in the US, extending this medicines potential benefits to even more patients facing high unmet needs and reinforcing AstraZenecas commitment to delivering innovative treatments across cardiovascular, renal and metabolic diseases. T2D is a chronic disease affecting people of all ages
But often times, you must look beyond exercise and nutrition and dig deeper into other aspects of health
TIGIT is involved in mediating NK cell self-tolerance to maintain regenerative hyperplasia by impeding NK cell activation and decreasing IFN- production
Risks include injection site reactions, rare allergic responses, and hypokalaemia during treatment of severe anaemia
Researchers report that patients taking GLP-1 receptor agonists can show atypical FDG uptake patterns that may be mistaken for disease
Mistakes happen when researchers apply reconstituted storage rules to lyophilized powder (unnecessarily restrictive) or, worse, apply lyophilized storage assumptions to reconstituted solution (dangerously lax)
